Conditions: Schizophrenia Schizoaffective Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 130
Healthy volunteers: no

Brief summary:
This study will assess whether olanzapine and/or risperidone affect the way the human body uses sugar in the blood.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: olanzapine intervention 2: risperidone
Intervention descriptions: intervention 1: 5-20 mg, oral, capsules, daily, 12 weeks. intervention 2: 2-6 mg, oral, capsules, twice daily (BID), 12 weeks.

Protocol document: